Amid all the trade-related headlines these days, it’s still crucial for us to keep up with new developments — regulatory or scientific — that could define or impact the future of many industries. After all, when a trade war is allowed to continue unchecked,… Read More
Genia Turanova, Chief Investment Strategist for Game-Changing Stocks and Fast-Track Millionaire, is a financial writer and money manager whose experience includes serving for more than a decade as a portfolio manager and Investment Committee member for a New York-based money management firm. Genia also researched, wrote and managed recommendations for several investment advisories. From 2011 to 2016, she served as Editor of the award-winning Leeb Income Performance newsletter. Genia also wrote for The Complete Investor, another award winner, from 2003 to 2016. During that time, Genia was responsible for several portfolios, including the "Income/Value" portfolio and the "FastTrack" portfolio. Genia's academic credentials include an MBA in Finance and Investments from the Zicklin School of Business, Baruch College in New York City. Genia is a CFA Charterholder.
Analyst Articles
Is The Market Ignoring Trump’s Trade War?
Last Friday, the tariff war started in earnest: the U.S. imposed $34 billion worth of tariffs on China and, in response, China said it applied its own tariffs on U.S. goods. —Recommended Link— How To Build A ‘Battle-Hardened’ Portfolio Did you know that no matter how big your nest egg is today…the odds of your grandchildren seeing a dime of inheritance is less than 10%? We’ve uncovered the solution to the 3rd generation curse–introducing our new Legacy Assets Portfolio. This collection of battle-hardened stocks is proven to generate income hand over fist… no matter what the market throws at… Read More
Last Friday, the tariff war started in earnest: the U.S. imposed $34 billion worth of tariffs on China and, in response, China said it applied its own tariffs on U.S. goods. —Recommended Link— How To Build A ‘Battle-Hardened’ Portfolio Did you know that no matter how big your nest egg is today…the odds of your grandchildren seeing a dime of inheritance is less than 10%? We’ve uncovered the solution to the 3rd generation curse–introducing our new Legacy Assets Portfolio. This collection of battle-hardened stocks is proven to generate income hand over fist… no matter what the market throws at it. It’s returned 45% gains to investors in just the past two years and turned every 50k into better than $100,000 in the last five. Click here to discover the recession-proof Legacy Assets your grandkids will thank you for. A ship laden with U.S. soybeans raced to arrive at its port of destination in northern China before the deadline, but it got there too late. Because the shipment reached Dalian hours after the deadline, the soybeans were subject to a 25% tariff. Other U.S.-made products subject to tariffs include agricultural products such as beef and pork, cars and “aquatic products”… Read More
Here’s A Schedule Of Your August Paychecks
The stated aim of The Daily Paycheck has always been “to help you reach the goal of receiving a dividend check for every day of the year.” Dividend payments tend to be concentrated, of course, but I’m happy to report that the number of paychecks reinvested in The… Read More
If You Own AT&T, You Need To Read This…
At long last, the merger between AT&T (NYSE: T) and Time Warner (NYSE: TWX) has closed. —Recommended Link— “I wish I’d done this 20 years ago.” That’s what a veteran investor and successful business owner told us… about a strategy called The Dividend Trifecta. He’s been using it for years, and for all the money he’s made in his life, this is the most consistent income stream he’s ever had. He’s not alone: investors in The Dividend Trifecta are telling us they’re making an extra $23,000 per year. Click here to see what they’re doing to make that kind… Read More
At long last, the merger between AT&T (NYSE: T) and Time Warner (NYSE: TWX) has closed. —Recommended Link— “I wish I’d done this 20 years ago.” That’s what a veteran investor and successful business owner told us… about a strategy called The Dividend Trifecta. He’s been using it for years, and for all the money he’s made in his life, this is the most consistent income stream he’s ever had. He’s not alone: investors in The Dividend Trifecta are telling us they’re making an extra $23,000 per year. Click here to see what they’re doing to make that kind of money. This act was completed on June 14. The telecom giant didn’t waste any time in taking control (after all, it had already waited as long as 20 months after the acquisition plan was announced on October 22, 2016). As you remember, on June 12, just two days before the acquisition closed, a federal judge ruled in AT&T’s favor, clearing the way (with no conditions imposed) for this mega-merger. And yes, it is indeed a mega-merger: AT&T’s cost to purchase the entertainment company was more than $100 billion (equity cost plus an assumption of debt). #-ad_banner-#>There are only a… Read More
I’m Continuing To Play Defense
Last Friday, the tariff war started in earnest: the U.S. imposed $34 billion worth of tariffs on China and, in response, China said it applied its own tariffs on U.S. goods. A ship laden with U.S. soybeans raced to arrive at its… Read More
When to Sell
Despite rising volatility and a slew of concerns about the world at large, the market has done well enough so far this year, especially given its exponential advance over the past few years. The Russell 2000 small-cap index is up 9.8%, while the S&P… Read More
I’m Sticking With CVS
The threat of competition from Amazon (Nasdaq: AMZN) — which has for some time been weighing on shares of drugstore companies such as Walgreens Boots Alliance (NYSE: WAG) and our portfolio’s CVS Health (NYSE: CVS) — looks as if it may actually materialize. This… Read More
At long last, the merger between AT&T (NYSE: T) and Time Warner (NYSE: TWX) has closed. This act was completed on June 14. The telecom giant didn’t waste any time in taking control (after all, it had already waited as long as… Read More
Think fast: What’s the first thing that comes to mind when you’re asked to imagine a cloud? Is it the white puffy thing that floats over our heads? What about “the” cloud – the storing and accessing of data and programs over the internet… Read More
Shares of our portfolio’s Sarepta (Nasdaq: SRPT), a gene therapy biotech with a gene-editing product addressing Duchenne muscular dystrophy (DMD), jumped more than 55% on the just-reported breakthrough results of its clinical study. Sarepta’s experimental gene therapy was shown to dramatically increase the production… Read More